Adult Dosing
Prevention or control of hypertensive episodes in the patient with pheochromocytoma
- Preoperative: 5 mg IM/IV 1-2 hrs prior to surgery. Dose may be repeated if required
- During surgery: 5 mg IV as indicated
Prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine
- For prevention: Add 10 mg of phentolamine to 1 L of solution containing norepinephrine
- For Treatment: 5-10 mg of phentolamine mesylate in 10 mL of saline is injected into the area of extravasation within 12 hrs
Diagnosis of pheochromocytoma - phentolamine blocking test
Intravenous
- 5 mg IV dissolved in 1 mL of sterile water for injection
- Record BP immediately after injection, at 30 sec intervals for the first 3 mins, and at 60-sec intervals for the next 7 mins
- Note that expected result consistent with pheochromocytoma is a 60 mmHg SBP and 25 mmHg DBP drop in 2 mins, with recovery of the pre-treatment blood pressure usually within 15-30 mins
Intramuscular
- 5 mg IM dissolved in 1 mL of sterile water for injection
- Record BP every 5 mins for 30-45 mins following injection
- Note that expected result consistent with pheochromocytoma is a 35 mmHg SBP and 25 mmHg DBP drop or more within 20 minutes
Reversal of the soft-tissue anesthesia with vasoconstrictor
- 0.2-0.8 mg given as a submucosal injection based on the amount of local anesthetic
Hypertensive Emergency [Non-FDA approved]
Pediatric Dosing
Prevention or control of hypertensive episodes in the patient with pheochromocytoma
- Preoperative: 1 mg IM/IV 1-2 hrs prior to surgery. Dose may be repeated if required
- During surgery: 1 mg IV as indicated
Diagnosis of pheochromocytoma - phentolamine blocking test
Intravenous
- 1 mg IV dissolved in 1 mL of sterile water for injection
- Record BP immediately after injection, at 30-sec intervals for the first 3 mins, and at 60-sec intervals for the next 7 mins
- Note that expected result consistent with pheochromocytoma is a 60 mmHg SBP and 25 mmHg DBP drop in 2 mins, with recovery of the pre-treatment blood pressure usually within 15-30 mins
Intramuscular
- 3 mg IM dissolved in 1 mL of sterile water for injection
- Record BP every 5 mins for 30 to 45 mins following injection
- Note that expected result consistent with pheochromocytoma is a 35 mmHg SBP and 25 mmHg DBP drop or more within 20 mins
Reversal of soft-tissue anesthesia with vasoconstrictor
- Child 6-12 yrs/ 15-30 kg: Dose given is based on the amount of local anesthetic. Max dose 0.2 mg submucosal injection
[Outline]
- Myocardial infarction, cerebrovascular spasm and cerebrovascular occlusion association with marked hypotension can occur with phentolamine. Monitor blood pressure for appropriate selection of patient, dosage and duration of therapy
- Phentolamine administration can cause tachycardia and cardiac arrhythmias
- Sulphites in phentolamine can cause hypersensitivity reactions especially in patients with bronchial asthma manifested as an acute asthma attack, or shock, or clouding of consciousness
- Phentolamine has stimulatory effect on gastrointestinal tract, including gastric secretion, use cautiously in patients with gastritis or peptic ulcer
- Phentolamine can cause CNS suppression. Warn patients against engaging in activities that require quick reactions, such as driving motor vehicles and operating machines
- The phentolamine blocking test should be reserved for cases in which additional confirmatory evidence is necessary and the relative risks involved in conducting the test have been considered
Caution: Use cautiously in
Pregnancy Category:C
Breastfeeding: Safety not established, because of the potential for possible serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.